-
Due to bankruptcy, a pharmaceutical company's "Drug Production License" was cancelled
Time of Update: 2020-09-18
The announcement said that the company was written off by the Jiange County Market Supervision Authority on August 10, 2020, because Sichuan Chunyu Pharmaceutical Co., Ltd. has been written off, has
-
Johnson and Johnson's new anti-tumor drug, Yondelis, was approved at the end of six years
Time of Update: 2020-08-12
recently announced that its anti-cancer drug Yondelis has been approved by the U.S. FDA for the treatment of soft tissue sarcoma.
2001, Johnson and Johnson obtained the drug from Zeltia, a Spanish pharmaceutical company, and began research on Yondelis's treatment of ovarian cancer.
-
Focus. True gold and silver support the biopharmaceutical industry Lanzhou High-tech Zone issued 20 biopharmaceutical industry development policies
Time of Update: 2020-07-18
Guide: Applicable to register and pay taxes in Lanzhou High-tech Zone, with independent legal personality, engaged in biopharmaceutical research and development, production and service enterprises and
-
Professor Liu Jian: China's biosimilardrugs meet international standards to meet the affordable drug needs of breast cancer patients
Time of Update: 2020-07-13
Breast cancer is the highest incidence of malignant tumors in women, the 5-year survival rate of about 70% to 90%, is also the number one cause of cancer death in women HER2-positive breast cancer
-
The re-emergence of the 4 plus 7 expansion varieties involves Entikawe, Atavastatin, Montiol scatter
Time of Update: 2020-07-09
On June 4, the Yunnan Provincial Medical Insurance Bureau issued a letter from the Yunnan Medical Security Bureau on the submission of a written statement of information and a list of production capac
-
News: 144 varieties transferred out of medical insurance (list attached
Time of Update: 2020-06-19
144 varieties will be transferred out before August 1 next year at the latest according to the industry news, some drugs will be transferred out of the notice of Sichuan basic medical reimbursement,
-
MD Biosciences, Kingsray Bio lead domestic and foreign CRO enterprises to debut 2014 China (Nanjing) International Biopharmaceutical Industry Expo
Time of Update: 2020-06-03
Business Agency, February 17 ( ) With the expiration of many drug patents, biopharmaceutical outsourcing services, also known as the Contract Research Organization (COW), has become more important,
-
Gilead Redsiewe is eligible for FDA orphan drug, expected to be market-exclusive for 7 years
Time of Update: 2020-05-31
On March 23, the FDA's website database showed that the FDA granted Gilead Sciences the qualification for the antiviral therapy reedsion drug Redesivir, whose indications are coronavirus disease 2019
-
"Medical Speed Reading Society" to open up the pharmaceutical market hong Kong Stock Exchange four provinces jointly purchase medical supplies
Time of Update: 2020-05-28
medical supplies with volume procurement! Yugui Yunyu four provincial alliance began to act 21, Chongqing Municipal Health Insurance Bureau, Guizhou Provincial Health Insurance Bureau, Yunnan Provi
-
Hand, foot and mouth disease enters a high-risk period, the relevant medical concept unit is concerned
Time of Update: 2020-05-28
Pharmaceutical Network Industry Dynamic " April to July is the high incidence of hand, foot and mouth disease, which is a common acute infectious disease in infants and young children under 5 years
-
Medical Representative: The time has come, the speed of transformation
Time of Update: 2020-05-11
Guide: Speed transformation! In 2020, the sales representative of foreign enterprises is difficult: on the one hand, because the epidemic led to the reduction of the amount of medicine and surgery,
-
The "weekend plus" model is encouraged to experiment, what do drug machine people think
Time of Update: 2020-04-26
Pharmaceutical Network Industry Dynamics" April 24, Anhui Province issued a notice, all kinds of units combined with their own actual implementation of the weekend 2.5 days of flexible rest, really p
-
Suspected anti-cancer drug kickbacks German police raided many doctors' residences
Time of Update: 2019-12-24
According to German media reports, on December 17, more than 10 doctors and pharmacists were suspected of corruption and their homes and offices were raided and searched by police According to prosecu
-
Zhanshi consulting 2019 Asia Pacific pharmaceutical intellectual property leaders summit successfully concluded in Beijing
Time of Update: 2019-11-18
The 2019 Asia Pacific pharmaceutical intellectual property leaders summit was officially held in Beijing on November 14 This summit was hosted by Shanghai Zhanshi Business Consulting Co., Ltd and brou
-
Dr. Kazmi of Novartis will be president and CEO of jubilant therapeutics Inc., a new innovative biopharmaceutical company in the United States
Time of Update: 2019-09-11
September 10, 2019 / AP / -- jubilant Life Sciences Limited announced that Syed Kazmi, M.B.A and Ph.D., would join jubilant therapeutics Inc., a new innovative biopharmaceutical company in the United
